🔗 Permalink

Inventor profile of:

Ulrich Brinkmann

City:

Weilheim

Country:

Germany

Published Applications:

Last publication date:

2025-11-27

Top Assignees for applications by Ulrich Brinkmann

The entities that hold a legal rights for patent applications filed by inventor Brinkmann Ulrich:

HOFFMANN-LA ROCHE INC. 43 Little Falls, NJ United States
Hoffmann-La Roche Inc. 11 Nutley, NJ United States
ROCHE GLYCART AG 4 Schlieren, Switzerland
Hoffman-La Roche Inc. 4 Little Falls, NJ United States
PGxHealth, LLC 3 Newton, MA United States
Epidauros Biotechnologie AG 2 Bernried, Germany
Hoffman-La Roche. Inc. 2 Nutley, NJ United States
Hoffmann-La Roche Inc. 1 Little Fall, NJ United States
Roche GlycArt AG 1 , Switzerland
Hoffmann-La Roche Inc. 1 South San FranciscoLittle Falls, NJ United States
The United States of America as represented by the Secretary of the Department of Health and Human Services 1 Washington, DC United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 1 Washington, DC United States
The United States of America as Represented by the Department of Health and Human Services 1 Washington, DC United States
EPIDAUROS Biotechnologie AG 1 Berlin, Germany

Recent patent applications by Brinkmann Ulrich

Ulrich Brinkmann from Weilheim, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-27

US20250361326A1

Chemistry; metallurgy

METHOD FOR GENERATING MULTISPECIFIC ANTIBODIES FROM MONOSPECIFIC ANTIBODIES

#2 | 2025-11-27

US20250361325A1

Chemistry; metallurgy

METHOD FOR GENERATING MULTISPECIFIC ANTIBODIES FROM MONOSPECIFIC ANTIBODIES

#3 | 2025-11-13

US20250346675A1

Chemistry; metallurgy

PAYLOAD-BEARING MULTISPECIFIC ANTIBODIES

#4 | 2025-08-14

US20250257104A1

Chemistry; metallurgy

TARGETED INTRACELLULAR DELIVERY OF LARGE NUCLEIC ACIDS

#5 | 2025-08-07

US20250250559A1

Chemistry; metallurgy

METHOD TO ANALYZE AND OPTIMIZE GENE EDITING MODULES AND DELIVERY APPROACHES

#6 | 2025-07-03

US20250215103A1

Chemistry; metallurgy

BISPECIFIC ANTIBODIES AND METHODS OF USE

#7 | 2024-11-14

US20240376205A1

Chemistry; metallurgy

TARGETED INTERFERON ALPHA FUSION PROTEINS AND METHODS OF USE

#8 | 2024-08-08

US20240262931A1

Chemistry; metallurgy

PRECURSOR PROTEINS AND KIT FOR TARGETED THERAPY

#9 | 2024-02-08

US20240043564A1

Chemistry; metallurgy

ANTI-BRDU ANTIBODIES AND METHODS OF USE

#10 | 2023-12-14

US20230399391A1

Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

#11 | 2022-03-31

US20220098326A1

Chemistry; metallurgy

METHOD FOR GENERATING AVID-BINDING MULTISPECIFIC ANTIBODIES

#12 | 2022-02-10

US20220041722A1

Chemistry; metallurgy

THERAPEUTIC MULTISPECIFIC POLYPEPTIDES ACTIVATED BY POLYPEPTIDE CHAIN EXCHANGE

#13 | 2022-02-03

US20220033526A1

Chemistry; metallurgy

ACTIVATABLE THERAPEUTIC MULTISPECIFIC POLYPEPTIDES WITH EXTENDED HALF-LIFE

#14 | 2022-02-03

US20220033525A1

Chemistry; metallurgy

GENERATION OF ANTIBODY-DERIVED POLYPEPTIDES BY POLYPEPTIDE CHAIN EXCHANGE

#15 | 2022-01-20

US20220017640A1

Chemistry; metallurgy

ACTIVATABLE BISPECIFIC ANTIBODIES

#16 | 2021-12-16

US20210388071A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#17 | 2021-04-22

US20210116455A1

Physics

SPECIFICITY ASSAY FOR NOVEL TARGET ANTIGEN BINDING MOIETIES

#18 | 2021-03-11

US20210069338A1

Human necessities

Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles

#19 | 2021-03-04

US20210061867A1

Chemistry; metallurgy

Targeted intracellular delivery of large nucleic acids

#20 | 2021-02-18

US20210047394A1

Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

#21 | 2021-01-28

US20210024648A1

Chemistry; metallurgy

MODIFIED PSEUDOMONAS EXOTOXIN A

#22 | 2020-12-17

US20200392254A1

Chemistry; metallurgy

Multispecific antibodies

#23 | 2020-08-20

US20200262904A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#24 | 2020-06-11

US20200181280A1

Chemistry; metallurgy

MODIFIED PSEUDOMONAS EXOTOXIN A

#25 | 2020-05-28

US20200164064A1

Human necessities

Covalently linked antigen-antibody conjugates

#26 | 2020-02-27

US20200062826A1

Chemistry; metallurgy

Trivalent, bispecific antibodies

#27 | 2020-01-02

US20200002437A1

Chemistry; metallurgy

Anti-BRDU antibodies and methods of use

#28 | 2020-01-02

US20200000929A1

Human necessities

Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles

#29 | 2019-09-12

US20190276850A1

Chemistry; metallurgy

METHOD TO ANALYZE AND OPTIMIZE GENE EDITING MODULES AND DELIVERY APPROACHES

#30 | 2018-10-04

US20180282404A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#31 | 2017-12-28

US20170369595A1

Chemistry; metallurgy

Multispecific antibodies

#32 | 2017-12-28

US20170369566A1

Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

#33 | 2017-04-27

US20170114150A1

Chemistry; metallurgy

ANTI-BRDU ANTIBODIES AND METHODS OF USE

#34 | 2017-03-02

US20170058051A1

Chemistry; metallurgy

Covalently linked polypeptide toxin-antibody conjugates

#35 | 2017-03-02

US20170058050A1

Chemistry; metallurgy

Covalently linked helicar-anti-helicar antibody conjugates and uses thereof

#36 | 2017-02-23

US20170051072A1

Chemistry; metallurgy

MODIFIED PSEUDOMONAS EXOTOXIN A

#37 | 2017-02-02

US20170029493A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#38 | 2016-11-10

US20160324984A1

Human necessities

Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles

#39 | 2016-01-14

US20160009823A1

Chemistry; metallurgy

Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent

#40 | 2015-10-08

US20150284457A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#41 | 2015-09-17

US20150258209A1

Human necessities

Covalently linked antigen-antibody conjugates

#42 | 2015-08-27

US20150239947A1

Chemistry; metallurgy

Cell-penetrating peptides and uses thereof

#43 | 2015-08-27

US20150238628A1

Human necessities

Anti-theophylline antibodies and methods of use

#44 | 2015-08-20

US20150232577A1

Chemistry; metallurgy

Anti-biotin antibodies and methods of use

#45 | 2015-04-09

US20150099707A1

Chemistry; metallurgy

Modified exotoxin A

#46 | 2015-01-15

US20150018229A1

Chemistry; metallurgy

POLYMORPHISMS IN THE HUMAN GENE FOR THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1 (MRP-1) AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

#47 | 2015-01-01

US20150004166A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#48 | 2014-05-15

US20140135482A1

Chemistry; metallurgy

Bispecific Anti ErbB3 / Anti cMet Antibodies

#49 | 2014-03-06

US20140065707A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#50 | 2014-03-06

US20140065151A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#51 | 2013-11-21

US20130309665A1

Chemistry; metallurgy

POLYMORPHISMS IN THE HUMAN GENE FOR THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1 (MRP-1) AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

#52 | 2013-10-24

US20130280279A1

Human necessities

PHARMACEUTICAL COMPOSITION OF A COMPLEX OF AN ANTI-DIG ANTIBODY AND DIGOXIGENIN THAT IS CONJUGATED TO A PEPTIDE

#53 | 2013-10-17

US20130273054A1

Chemistry; metallurgy

Bispecific Anti ErbB2/Anti cMet Antibodies

#54 | 2013-10-10

US20130267686A1

Chemistry; metallurgy

Bispecific antibodies comprising a disulfide stabilized-Fv fragment

#55 | 2013-10-10

US20130266568A1

Chemistry; metallurgy

ACTIVATABLE BISPECIFIC ANTIBODIES

#56 | 2013-06-27

US20130164219A1

Chemistry; metallurgy

Cell-penetrating peptides and uses thereof

#57 | 2013-06-20

US20130156789A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#58 | 2013-06-20

US20130156772A1

Chemistry; metallurgy

Bispecific Anti ErbB1 / Anti cMet Antibodies

#59 | 2013-01-24

US20130022601A1

Chemistry; metallurgy

Trivalent, bispecific antibodies

#60 | 2012-12-20

US20120321627A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#61 | 2012-11-08

US20120282280A1

Chemistry; metallurgy

Bi-specific digoxigenin binding antibodies

#62 | 2012-10-25

US20120269723A1

Chemistry; metallurgy

Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent

#63 | 2012-07-26

US20120190017A1

Chemistry; metallurgy

POLYMORPHISMS IN THE HUMAN GENE FOR THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1 (MRP-1) AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

#64 | 2012-06-14

US20120149879A1

Chemistry; metallurgy

BISPECIFIC ANTI-EGFR/ANTI-IGF-1R ANTIBODIES

#65 | 2012-06-07

US20120142091A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#66 | 2012-06-07

US20120141500A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#67 | 2011-12-01

US20110293613A1

Chemistry; metallurgy

Bispecific antibodies

#68 | 2011-07-28

US20110183354A1

Chemistry; metallurgy

HUMAN Fc GAMMA RECEPTOR III

#69 | 2011-06-02

US20110131671A1

Chemistry; metallurgy

POLYMORPHISMS IN THE HUMAN GENE FOR CYTOCHROME P450 POLYPEPTIDE 2C8 AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

#70 | 2010-10-07

US20100256340A1

Chemistry; metallurgy

TRIVALENT, BISPECIFIC ANTIBODIES

#71 | 2010-10-07

US20100256339A1

Human necessities

Bispecific Anti ErbB3 / Anti cMet Antibodies

#72 | 2010-10-07

US20100256338A1

Chemistry; metallurgy

Multispecific antibodies comprising full length antibodies and single chain fab fragments

#73 | 2010-10-07

US20100254989A1

Human necessities

Bispecific Anti ErbB1 / Anti c Met Antibodies

#74 | 2010-10-07

US20100254988A1

Human necessities

Bispecific Anti ErbB2 / Anti cMet Antibodies

#75 | 2010-06-24

US20100159587A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#76 | 2010-05-06

US20100111967A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#77 | 2010-04-01

US20100081796A1

Chemistry; metallurgy

BISPECIFIC ANTI-EGFR/ANTI-IGF-1R ANTIBODIES

#78 | 2010-01-14

US20100009366A1

Chemistry; metallurgy

POLYMORPHISMS IN THE HUMAN GENES FOR OCT1 AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

#79 | 2009-06-04

US20090144841A1

Chemistry; metallurgy

Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications

#80 | 2009-03-05

US20090061452A1

Chemistry; metallurgy

Polymorphisms in the human genes for OCT 1 and their use in diagnostic and therapeutic applications

#81 | 2009-01-15

US20090018030A1

Chemistry; metallurgy

Polymorphisms in the human genes for OCT1 and their use in diagnostic and therapeutic applications

#82 | 2008-10-09

US20080248510A1

Chemistry; metallurgy

HUMAN Fc GAMMA RECEPTOR III

#83 | 2008-07-15

US9763393

Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor

#84 | 2007-10-25

US20070248972A1

Chemistry; metallurgy

Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor

#85 | 2006-08-03

US20060172291A1

Chemistry; metallurgy

Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic applications

#86 | 2006-06-08

US20060122372A1

Chemistry; metallurgy

Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications

#87 | 2006-05-30

US10031158

T-cell receptorγ alternate reading frame protein, (TARP) and uses thereof

InventorID:

52375 ⎘